Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis

Fernanda Pimentel de Araujo, Fabio D’Ambrosio, Romina Camilli, Ersilia Fiscarelli, Giovanni Di Bonaventura, Lucilla Baldassarri, Paolo Visca, Annalisa Pantosti, Giovanni Gherardi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The role of Streptococcus pneumoniae in cystic fibrosis (CF) is poorly understood. The pneumococcal population has changed over time after the introduction of the heptavalent conjugate vaccine (PCV7) and, more recently, the 13-valent conjugate vaccine (PCV13). Although serotypes and clones causing invasive pneumococcal disease or colonizing healthy children have been extensively analysed, little is known so far on the serotypes and clones of pneumococci in CF patients. The aim of this work was to investigate serotypes, antibiotic susceptibilities, genotypes and biofilm production of CF pneumococcal isolates. Overall, 44 S. pneumoniae strains collected from 32 paediatric CF patients from January 2010 to May 2012 in a large Italian CF Centre were tested for antimicrobial susceptibility testing by Etest, serotyped by the Quellung reaction and genotyped by a combination of different molecular typing methods, including pbp gene restriction profiling, pspA restriction profiling and sequencing, PFGE and multilocus sequence typing. Biofilm production by pneumococcal strains was also assessed. Penicillin non-susceptibility was 16%. High resistance rates (>56%) were observed for erythromycin, clindamycin and tetracycline. The most frequent serotype recovered was serotype 3 (31.8%). The coverage of PCV7 and PCV13 was 6.8 and 47.7%, respectively. More than 80% of CF strains belonged to Pneumococcal Molecular Epidemiology Network (PMEN) reference clones, the most common being Netherlands3-ST180 (28.2%), and Greece21-30/ST193 (15.4%). All strains produced biofilm in vitro, although with large variability in biofilm formation efficiency. No correlation was found between biofilm levels and serotype, clone or antibiotic resistance. The high isolation rate of antibiotic-resistant serotype 3 pneumococci from CF patients suggests that PCV13 could increase protection from pneumococcal colonization and infection.

Original languageEnglish
Article number072199
Pages (from-to)1704-1715
Number of pages12
JournalJournal of Medical Microbiology
Volume63
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

Streptococcus pneumoniae
Cystic Fibrosis
Clone Cells
Biofilms
Pediatrics
Conjugate Vaccines
Disk Diffusion Antimicrobial Tests
Anti-Bacterial Agents
Multilocus Sequence Typing
Pneumococcal Infections
Molecular Typing
Molecular Epidemiology
Clindamycin
Erythromycin
Microbial Drug Resistance
Serogroup
Tetracycline
Penicillins
Genotype
Population

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology
  • Medicine(all)

Cite this

de Araujo, F. P., D’Ambrosio, F., Camilli, R., Fiscarelli, E., Di Bonaventura, G., Baldassarri, L., ... Gherardi, G. (2014). Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis. Journal of Medical Microbiology, 63, 1704-1715. [072199]. https://doi.org/10.1099/jmm.0.072199-0

Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis. / de Araujo, Fernanda Pimentel; D’Ambrosio, Fabio; Camilli, Romina; Fiscarelli, Ersilia; Di Bonaventura, Giovanni; Baldassarri, Lucilla; Visca, Paolo; Pantosti, Annalisa; Gherardi, Giovanni.

In: Journal of Medical Microbiology, Vol. 63, 072199, 01.12.2014, p. 1704-1715.

Research output: Contribution to journalArticle

de Araujo, FP, D’Ambrosio, F, Camilli, R, Fiscarelli, E, Di Bonaventura, G, Baldassarri, L, Visca, P, Pantosti, A & Gherardi, G 2014, 'Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis', Journal of Medical Microbiology, vol. 63, 072199, pp. 1704-1715. https://doi.org/10.1099/jmm.0.072199-0
de Araujo, Fernanda Pimentel ; D’Ambrosio, Fabio ; Camilli, Romina ; Fiscarelli, Ersilia ; Di Bonaventura, Giovanni ; Baldassarri, Lucilla ; Visca, Paolo ; Pantosti, Annalisa ; Gherardi, Giovanni. / Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis. In: Journal of Medical Microbiology. 2014 ; Vol. 63. pp. 1704-1715.
@article{d52bada6064a4fb195f2f483c60270e7,
title = "Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis",
abstract = "The role of Streptococcus pneumoniae in cystic fibrosis (CF) is poorly understood. The pneumococcal population has changed over time after the introduction of the heptavalent conjugate vaccine (PCV7) and, more recently, the 13-valent conjugate vaccine (PCV13). Although serotypes and clones causing invasive pneumococcal disease or colonizing healthy children have been extensively analysed, little is known so far on the serotypes and clones of pneumococci in CF patients. The aim of this work was to investigate serotypes, antibiotic susceptibilities, genotypes and biofilm production of CF pneumococcal isolates. Overall, 44 S. pneumoniae strains collected from 32 paediatric CF patients from January 2010 to May 2012 in a large Italian CF Centre were tested for antimicrobial susceptibility testing by Etest, serotyped by the Quellung reaction and genotyped by a combination of different molecular typing methods, including pbp gene restriction profiling, pspA restriction profiling and sequencing, PFGE and multilocus sequence typing. Biofilm production by pneumococcal strains was also assessed. Penicillin non-susceptibility was 16{\%}. High resistance rates (>56{\%}) were observed for erythromycin, clindamycin and tetracycline. The most frequent serotype recovered was serotype 3 (31.8{\%}). The coverage of PCV7 and PCV13 was 6.8 and 47.7{\%}, respectively. More than 80{\%} of CF strains belonged to Pneumococcal Molecular Epidemiology Network (PMEN) reference clones, the most common being Netherlands3-ST180 (28.2{\%}), and Greece21-30/ST193 (15.4{\%}). All strains produced biofilm in vitro, although with large variability in biofilm formation efficiency. No correlation was found between biofilm levels and serotype, clone or antibiotic resistance. The high isolation rate of antibiotic-resistant serotype 3 pneumococci from CF patients suggests that PCV13 could increase protection from pneumococcal colonization and infection.",
author = "{de Araujo}, {Fernanda Pimentel} and Fabio D’Ambrosio and Romina Camilli and Ersilia Fiscarelli and {Di Bonaventura}, Giovanni and Lucilla Baldassarri and Paolo Visca and Annalisa Pantosti and Giovanni Gherardi",
year = "2014",
month = "12",
day = "1",
doi = "10.1099/jmm.0.072199-0",
language = "English",
volume = "63",
pages = "1704--1715",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",

}

TY - JOUR

T1 - Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis

AU - de Araujo, Fernanda Pimentel

AU - D’Ambrosio, Fabio

AU - Camilli, Romina

AU - Fiscarelli, Ersilia

AU - Di Bonaventura, Giovanni

AU - Baldassarri, Lucilla

AU - Visca, Paolo

AU - Pantosti, Annalisa

AU - Gherardi, Giovanni

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The role of Streptococcus pneumoniae in cystic fibrosis (CF) is poorly understood. The pneumococcal population has changed over time after the introduction of the heptavalent conjugate vaccine (PCV7) and, more recently, the 13-valent conjugate vaccine (PCV13). Although serotypes and clones causing invasive pneumococcal disease or colonizing healthy children have been extensively analysed, little is known so far on the serotypes and clones of pneumococci in CF patients. The aim of this work was to investigate serotypes, antibiotic susceptibilities, genotypes and biofilm production of CF pneumococcal isolates. Overall, 44 S. pneumoniae strains collected from 32 paediatric CF patients from January 2010 to May 2012 in a large Italian CF Centre were tested for antimicrobial susceptibility testing by Etest, serotyped by the Quellung reaction and genotyped by a combination of different molecular typing methods, including pbp gene restriction profiling, pspA restriction profiling and sequencing, PFGE and multilocus sequence typing. Biofilm production by pneumococcal strains was also assessed. Penicillin non-susceptibility was 16%. High resistance rates (>56%) were observed for erythromycin, clindamycin and tetracycline. The most frequent serotype recovered was serotype 3 (31.8%). The coverage of PCV7 and PCV13 was 6.8 and 47.7%, respectively. More than 80% of CF strains belonged to Pneumococcal Molecular Epidemiology Network (PMEN) reference clones, the most common being Netherlands3-ST180 (28.2%), and Greece21-30/ST193 (15.4%). All strains produced biofilm in vitro, although with large variability in biofilm formation efficiency. No correlation was found between biofilm levels and serotype, clone or antibiotic resistance. The high isolation rate of antibiotic-resistant serotype 3 pneumococci from CF patients suggests that PCV13 could increase protection from pneumococcal colonization and infection.

AB - The role of Streptococcus pneumoniae in cystic fibrosis (CF) is poorly understood. The pneumococcal population has changed over time after the introduction of the heptavalent conjugate vaccine (PCV7) and, more recently, the 13-valent conjugate vaccine (PCV13). Although serotypes and clones causing invasive pneumococcal disease or colonizing healthy children have been extensively analysed, little is known so far on the serotypes and clones of pneumococci in CF patients. The aim of this work was to investigate serotypes, antibiotic susceptibilities, genotypes and biofilm production of CF pneumococcal isolates. Overall, 44 S. pneumoniae strains collected from 32 paediatric CF patients from January 2010 to May 2012 in a large Italian CF Centre were tested for antimicrobial susceptibility testing by Etest, serotyped by the Quellung reaction and genotyped by a combination of different molecular typing methods, including pbp gene restriction profiling, pspA restriction profiling and sequencing, PFGE and multilocus sequence typing. Biofilm production by pneumococcal strains was also assessed. Penicillin non-susceptibility was 16%. High resistance rates (>56%) were observed for erythromycin, clindamycin and tetracycline. The most frequent serotype recovered was serotype 3 (31.8%). The coverage of PCV7 and PCV13 was 6.8 and 47.7%, respectively. More than 80% of CF strains belonged to Pneumococcal Molecular Epidemiology Network (PMEN) reference clones, the most common being Netherlands3-ST180 (28.2%), and Greece21-30/ST193 (15.4%). All strains produced biofilm in vitro, although with large variability in biofilm formation efficiency. No correlation was found between biofilm levels and serotype, clone or antibiotic resistance. The high isolation rate of antibiotic-resistant serotype 3 pneumococci from CF patients suggests that PCV13 could increase protection from pneumococcal colonization and infection.

UR - http://www.scopus.com/inward/record.url?scp=84919361169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919361169&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.072199-0

DO - 10.1099/jmm.0.072199-0

M3 - Article

VL - 63

SP - 1704

EP - 1715

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

M1 - 072199

ER -